Clinical Trial Finds Well Tolerated Vaccine for Aggressive Breast CancerA small clinical trial shows promising results for ...

If your under-eyes are looking puffy, dark and tired, we're happy to report that there's an easy — and tres affordable — fix.

“It’s truly one of the most versatile ingredients we have,” explains board-certified dermatologist Dhaval Bhanusali, M.D.

Eczema cases are rising in areas with high air pollution, according to a Yale University study. Exposure to fine particulate ...

As the seasons change, your skin-care routine might need to change too. Prevent and soothe dry, irritated winter skin with ...

Primary outcomes include efficacy with regards to clinician-reported signs and patient-reported symptoms and safety with regards to withdrawal from treatment due to adverse ... including studies on ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Makeup Revolution, Lush, Boots, Bubble T and more advent calendars are available this year, here are our favourites.

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

Makeup Revolution, Lush, Boots, Bubble T and more advent calendars are available this year, here are our favourites.